New research presented at ACR Convergence, the American College Rheumatology's annual meeting, showed that patients with rheumatic diseases whose infliximab treatment was individually assessed and adjusted with a new strategy ...
Nov 6, 2020
0
1
Brepocitinib is an oral drug that inhibits certain enzymes involved in inflammation—called tyrosine kinase 2 and Janus kinase 1—and is being tested for the treatment of several immunological diseases. A phase IIb randomized ...
May 17, 2023
0
2
Two drugs commonly used to treat inflammatory diseases such as rheumatoid arthritis and psoriasis did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared ...
Jul 10, 2023
0
35
A University of Toronto scientist has developed a new method for identifying the raw ingredients necessary to build 'biologics', a powerful class of medications that has revolutionized treatment of diseases like rheumatoid ...
Jul 21, 2016
0
4
Clad in white lab coats, blue gloves and safety goggles, scientists are buzzing around a lab at Hospira in this suburb north of Chicago.
Mar 31, 2015
0
8
The American College of Physicians (ACP) today provided physician perspective on the escalating cost of prescription drugs, the impact of the costs on internal medicine physicians and their patients, and support for the intent ...
Jun 21, 2016
0
1
Different people taking the same drug can have markedly different responses to the same dose. While many people will get the intended effects, some may get little to no benefit, and others may get unwanted side effects.
Oct 5, 2021
0
4
The German Institute for Quality and Efficiency in Health Care (IQWiG) examined 9 biotechnologically produced drugs for the treatment of adults with rheumatoid arthritis in whom prior pharmacological treatment had failed. ...
Aug 30, 2013
0
0
Berlin, Germany, June 7 2012: Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tailoring biologic treatment to individual patients with rheumatoid arthritis ...
Jun 7, 2012
0
0
Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.
Nov 20, 2020
0
1
